[ad_1]
The FDA advisory agency recommended this week to vaccinate the coronavirus booster for people over 65 years of age and at high risk.
After the Food and Drug Administration (FDA) expert advisory panel this week, senior US health officials stated that it may take several weeks to obtain approval for a broader COVID-19 booster injection Respected The third jab for a limited part of the population.
The President of the National Institutes of Health said that the FDA team’s decision on Friday to restrict Pfizer’s COVID-19 booster injections to Americans 65 years and older and high-risk groups with serious illnesses is an initial step.
In an interview with “Fox Sunday News”, Dr. Francis Collins predicted that “in the next few weeks” most Americans will receive wider support.
Collins said that based on a “snapshot” of existing data on the effectiveness of Pfizer’s two-needle therapy over time, the expert group’s recommendations are correct. But he said that real-time data from the United States and Israel continue to show that the efficacy is diminishing in a wider population that needs to be addressed as soon as possible.
“I think a decision will be made in the next few weeks to extend the booster beyond the list they approved on Friday,” said Collins, who also appeared on CBS’s “Face the Country” program on Sunday.
Some wealthy countries, including the United States and the United Kingdom, are considering coronavirus vaccination due to the recent surge in cases related to the new coronavirus The highly contagious Delta variant.
But the World Health Organization (WHO) this month Call Because of concerns about providing vaccines to poorer countries, millions of people have not yet received the first injection, so the booster injection has been suspended.
A group of international scientists Said last week Even if there is a threat from Delta Air Lines, “in the current stage of the pandemic, it is not appropriate to give a booster dose to the general population.”
The scientists wrote in the “Lancet” medical journal: “Any decision about whether to enhance or enhance time should be based on a careful analysis of adequately controlled clinical or epidemiological data or both, indicating the persistence of severe disease. And meaningful reduction.”
Dr. Anthony Fauci, the chief medical adviser to US President Joe Biden, praised the FDA’s advisory committee’s plan to reach a “large number” of Americans on Sunday. But he emphasized that based on constantly changing data, “this is not the end of the story,” and said that these suggestions may be expanded in the coming weeks to months.
Americans who have received two doses of Moderna vaccine or one dose of Johnson & Johnson vaccine are still waiting for guidance on possible booster injections.
“The actual data we will get [on] The third shot of Moderna and the second shot of J&J actually take several to several weeks,” Fauci said in an interview with NBC media.
“We are now working to provide the data to the FDA so that they can inspect and identify these people’s boosters.”
The FDA will consider the advice of the advisory group and make its own decision, possibly within a few days. The Centers for Disease Control and Prevention (CDC) will also weigh in this week.
[ad_2]
Source link